Biowaiver monographs for immediate release solid oral dosage forms: Cimetidine
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing cimetidine are reviewed. According to the current Biopharmaceutics Classification System (BCS), cimetidine would be assigned...
Saved in:
Main Authors: | E. Jantratid, S. Prakongpan, J. B. Dressman, G. L. Amidon, H. E. Junginger, K. K. Midha, D. M. Barends |
---|---|
Other Authors: | Mahidol University |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/23913 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biowaiver monographs for immediate release solid oral dosage forms: Lamivudine
by: S. Strauch, et al.
Published: (2018) -
Biowaiver monographs for immediate release solid oral dosage forms: Mefloquine hydrochloride
by: S. Strauch, et al.
Published: (2018) -
Feasibility of biowaiver extension to Biopharmaceutics Classification System Class III drug products: Cimetidine
by: Ekarat Jantratid, et al.
Published: (2018) -
The biowaiver procedure: Its application to antituberculosis products in the WHO prequalification programme
by: Stefanie Strauch, et al.
Published: (2018) -
Convenient and rapid determination of cimetidine in human plasma using perchloric acid-mediated plasma protein precipitation and high-performance liquid chromatography
by: Ekarat Jantratid, et al.
Published: (2018)